Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A

Izgia K., Iskender B., Sakalar C., Arslanhan A., Yuksek E. H., Hizar E., ...Daha Fazla

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, cilt.17, sa.3, ss.404-414, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.2174/1871520616666160404110543
  • Dergi Adı: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.404-414
  • Anahtar Kelimeler: Myrtucommulone A, Cancer, Cisplatin, Epirubicin, 4T1, Cancer resistance, GENE-EXPRESSION PATTERNS, NF-KAPPA-B, BCL-W, INDUCED APOPTOSIS, TRAIL-RESISTANCE, PROTEIN-LEVELS, P53, FAMILY, ACTIVATION, DEATH
  • Kocaeli Üniversitesi Adresli: Hayır

Özet

Background: The number of cancer cases around the world has increased according to the World Health Organization (WHO) reports, nearly 14 million new cases and 8.2 million cancer associated mortalities have been reported in 2012. Chemotherapeutic resistance is a major problematic issue in the management of patients with breast tumor.